What is the current Price Target for the Replimune Group, Inc. stock?

The average Replimune Group, Inc. target price is $19.38. This is 54.30% higher than the current stock price. The highest price target is 67.20%, the lowest is -83.92%. 8 Analysts have issued a price target Replimune Group, Inc. 2027 .

How high will the Replimune Group, Inc. stock rise?

No reliable answer can be given as to how high the Replimune Group, Inc. stock will rise. The performance of stocks, including the Replimune Group, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Replimune Group, Inc. stock today?

The performance of Replimune Group, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Replimune Group, Inc. stock fall?

The decline in Replimune Group, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Replimune Group, Inc. Forecast, price target & analysts

$12.56

1.62%

Nasdaq, Sep 28, 04:13 pm EDT. Closed.

ISIN

US76029N1063

Symbol

REPL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Replimune Group, Inc. Target price 2026 - Analyst rating & recommendation

Replimune Group, Inc. Classifications & Recommendation

Buy

86%

Hold

Sell

Replimune Group, Inc. Price Target

Target Price	$19.38
Price	$12.56
Potential	54.30% register free of charge
Number of Estimates	8

	8 Analysts have issued a price target Replimune Group, Inc. 2027 . The average Replimune Group, Inc. target price is $19.38. This is 54.30% register free of charge higher than the current stock price. The highest price target is $21.00 67.20% register free of charge , the lowest is $2.02 83.92% register free of charge .
	A rating was issued by 14 analysts: 12 Analysts recommend Replimune Group, Inc. to buy, 1 to hold and 1 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Replimune Group, Inc. stock has an average upside potential 2027 of 54.30% register free of charge . Most analysts recommend the Replimune Group, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2033

Create a premium account to unlock analyst estimates. Learn more

Annually

	Mar '26	2027 Estimates
Earnings Per Share $	-3.38	-2.92
	10.10%	13.61%
P/E		negative
EV/Sales		26.62

10 Analysts have issued a Replimune Group, Inc. forecast for earnings per share. The average Replimune Group, Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2026. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2026	$-3.38	10.10%
2027	$-2.92 13.61% unlock
2028	$-2.48 15.07% unlock
2029	$-0.24 90.32% unlock
2030	$-0.34 41.67% unlock
2031	$-0.06 82.35% unlock
2032	$0.31 616.67% unlock
2033	$0.40 29.03% unlock

Current	-4.04	283.26%
2027	-4.24 4.97% unlock
2028	-4.99 17.69% unlock
2029	-50.49 911.82% unlock
2030	-36.17 28.36% unlock
2031	-220.32 509.12% unlock
2032	40.39 118.33% unlock
2033	31.07 23.08% unlock

Replimune Group, Inc....

Current Replimune Group, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
JP Morgan	Locked ➜ Locked	Locked	Aug 26 2026
Wedbush	Locked ➜ Locked	Locked	Aug 07 2026
JP Morgan	Locked ➜ Locked	Locked	Aug 07 2026
Leerink Partners	Locked ➜ Locked	Locked	Aug 04 2026
Cantor Fitzgerald	Locked ➜ Locked	Locked	Jul 31 2026
Wedbush	Locked ➜ Locked	Locked	Jul 31 2026
Wedbush	Locked ➜ Locked	Locked	Jun 30 2026

Analyst Rating	Date
Locked JP Morgan: Locked ➜ Locked	Aug 26 2026
Locked Wedbush: Locked ➜ Locked	Aug 07 2026
Locked JP Morgan: Locked ➜ Locked	Aug 07 2026
Locked Leerink Partners: Locked ➜ Locked	Aug 04 2026
Locked Cantor Fitzgerald: Locked ➜ Locked	Jul 31 2026
Locked Wedbush: Locked ➜ Locked	Jul 31 2026
Locked Wedbush: Locked ➜ Locked	Jun 30 2026

Discover more stocks with a high price target

NIO ADR 104.00%

Alibaba Group Holding Ltd 71.25%

Rheinmetall 68.89%

Infineon 63.18%

Adyen 55.40%

Tencent Holdings Ltd. 55.39%

TUI 52.20%

Uber Technologies 51.14%

Siemens Energy 48.42%

BYD 47.84%

Adidas 41.08%

Netflix 39.97%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now